2021
TCL-194: Change in Lymphocyte Count as a Predictor of Response to Mogamulizumab in Patients with Mycosis Fungoides or Sézary Syndrome
Foss F, Ito T, Dwyer K, Herr F. TCL-194: Change in Lymphocyte Count as a Predictor of Response to Mogamulizumab in Patients with Mycosis Fungoides or Sézary Syndrome. Clinical Lymphoma Myeloma & Leukemia 2021, 21: s412. DOI: 10.1016/s2152-2650(21)01926-1.Peer-Reviewed Original ResearchGrade 0Blood involvementSézary syndromeMycosis fungoidesB2 patientsLymphocyte countClinical responseSézary cellsGrade 1Refractory mycosis fungoidesSeverity of lymphopeniaAbsolute lymphocyte countSkin responseT lymphocyte populationsPredictors of responseIncidence of infectionAnti-CCR4 antibodyMechanism of actionAbsolute lymphocyteAdvanced diseaseClinical outcomesLymphocyte populationsInfections/infestationsMogamulizumabT cells
2001
Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis
Akpek G, Lenz G, Lee S, Sanchorawala V, Wright D, Colarusso T, Waraska K, Lerner A, Vosburgh E, Skinner M, Comenzo R. Immunologic recovery after autologous blood stem cell transplantation in patients with AL-amyloidosis. Bone Marrow Transplantation 2001, 28: 1105-1109. PMID: 11803350, DOI: 10.1038/sj.bmt.1703298.Peer-Reviewed Original ResearchConceptsStem cell transplantationAutologous blood stem cell transplantationBlood stem cell transplantationAbsolute lymphocyteT cellsImmunoglobulin levelsCell transplantationAL amyloidosisProliferative responsePost-stem cell transplantationT cell proliferative responsesNumber of CD4Post-transplant immunosuppressionCellular immune functionSerum immunoglobulin levelsT-cell immunosuppressionCell proliferative responsesT cell proliferationB cell functionInitial study groupImmunologic recoveryLymphoid recoveryPCP pneumoniaCell immunosuppressionLymphocyte subsets
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply